Volv Global generates insights that create new understanding of disease progression, the patient journey, and close the gap between disease onset and treatment.
We help transform lives by giving pharmaceutical innovators powerful insights into difficult-to-diagnose diseases so they can develop effective tools and treatments.
For the person living with the disease, this results in quicker diagnosis, earlier support from clinicians and the possibility of innovative treatments – whether that’s a new drug or an existing one used in a novel way
Volv Global works directly with the pharmaceutical companies developing the next generation of therapies. We cannot support individual patients as we do not have connections with physicians or healthcare providers at the local or regional level.
Recognising that patients living with difficult-to-diagnose diseases may also arrive on our pages, we attempt, below, to offer a few lists of resources for possible approach. This list is necessarily incomplete, and we will continue to update it as we learn more.
Please note: Volv Global has no official affiliation with any of the organisations mentioned on this page.
Volv Global started in rare and difficult-to-diagnose diseases
Rare diseases manifest in less than one person among thousands. Doctors have less experience with them, and developers of therapies and payers have less patients to draw understanding from … leaving patients in a healthcare limbo.
Depending on definitions of “rare,” over 300 million people – or 3.5-5.9% of the world population – suffer from 6,000-10,000 rare diseases.
Please note: Volv Global has no official affiliation with these organisations.
Upon diagnosis, patients need a deep and thorough understanding of the disease and the likelihood of how the disease will progress.
Patients also require support to understand treatment options, as well as availability in their geographical location. In certain cases, awareness of available clinical research trials may be useful.
Please note: Volv Global has no official affiliation with these organisations.
Ready to shape the future of healthcare? Let’s explore how our machine learning solutions can accelerate diagnoses, refine patient journeys, and drive meaningful impact for those who need it most. We value your ideas and expertise, reach out now to unlock new possibilities together.
